Thomas James Doyle, SVP, Finance & Accounting at Kura Oncology, Inc. (KURA), sold 4,607 shares at $10.50 ($48K) on 2026-09-28, disclosed to the SEC on 2026-09-29.
Open-market sale of $48k KURA by SVP, Finance & Accounting. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| KURA | SELL | 2025-09-29 | $41K | — | Filing → |
| KURA | SELL | 2025-01-28 | $39K | — | Filing → |
| KURA | SELL | 2024-01-31 | $41K | — | Filing → |